Lysosomal acid lipase (LAL) deficiency is an under-recognized lysosomal disease caused by deficient enzymatic activity of LAL. In this report we describe two affected female Mexican siblings with early hepatic complications. At two months of age, the first sibling presented with alternating episodes of diarrhea and constipation, and later with hepatomegaly, elevated transaminases, high levels of total and low-density lipoprotein cholesterol, and low levels of high-density lipoprotein. Portal hypertension and grade 2 esophageal varices were detected at four years of age. The second sibling presented with hepatomegaly, elevated transaminases and mildly elevated low-density lipoprotein and low high-density lipoprotein at six months of age. LAL activity was deficient in both patients. Sequencing of LIPA revealed two previously unreported heterozygous mutations in exon 4: c.253C>A and c.294C>G. These cases highlight the clinical continuum between the so-called Wolman disease and cholesteryl ester storage disease, and underscore that LAL deficiency represents a single disease with a degree of clinical heterogeneity.
Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency.
墨西哥溶酶体酸性脂肪酶缺乏症患者兄弟姐妹中发现新的 LIPA 基因突变
阅读:7
作者:Santillán-Hernández Yuritzi, Almanza-Miranda Enory, Xin Winnie W, Goss Kendrick, Vera-Loaiza Aurea, Gorráez-de la Mora MarÃa T, Piña-Aguilar Raul E
| 期刊: | World Journal of Gastroenterology | 影响因子: | 5.400 |
| 时间: | 2015 | 起止号: | 2015 Jan 21; 21(3):1001-8 |
| doi: | 10.3748/wjg.v21.i3.1001 | 研究方向: | 其它 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
